NCT07452120
DIPB vs. SIFIB for Postoperative Analgesia After Hip Surgery
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 11 words
- Study completion pushed from Nov 1, 2026 to Feb 1, 2027
- Publications: details revised at 4 of 4 entries
- Notable Recruitment opened
- Study sites: 1 to 2
- Start date changed from estimate of Apr 1, 2026 to Mar 27, 2026
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Secondary (3)
Arms and interventions
Participants randomized to this arm will receive an ultrasound-guided suprainguinal fascia iliaca compartment block at the end of surgery using 0.25% bupivacaine (30-40 mL, weight-adjusted) for postoperative analgesia following primary total hip arthroplasty.
Participants randomized to this arm will receive an ultrasound-guided deep iliacus plane block at the end of surgery using 0.25% bupivacaine (30-40 mL, weight-adjusted) for postoperative analgesia following primary total hip arthroplasty.
Procedures: Suprainguinal Fascia Iliaca Block, Deep Iliacus Plane Block
Sites
2 sites in 1 country